Navigation Links
European Health Care Institutions Forced to Select Lower-Priced Interventional Cardiology Devices
Date:7/9/2009

WALTHAM, Mass., July 9 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the ongoing economic crisis is putting pressure on publicly-funded health care systems across Europe, intensifying the decline of interventional cardiology (IC) device prices in the region. MRG's European Markets for Interventional Cardiology Devices 2009 (Part II) report details the extent to which competitive pricing and discounts among IC device vendors is resulting in price erosion in Belgium, Luxembourg, the Netherlands, Norway, Denmark, Finland, Sweden, Spain, and Switzerland.

IC device vendors are engaging in price undercutting and offering high-volume discounts or bundling deals with other products in their portfolios in order to encourage sales, resulting in price erosion. The health care systems in the Netherlands and Switzerland (beginning in 2012) provide only general funding for IC procedures, despite the varying cost of devices used. In order to operate within set budgets, European health care facilities must often choose lower-cost devices. Contract tenders between sellers and group purchasing organizations will further add to price erosion. In exchange for high-volume sales of their products, manufacturers offer significant discounts. This method of business is becoming more common across Europe, particularly in the Nordic countries and Spain.

"The global economic recession has certainly intensified the extent of price erosion for IC devices across Europe," says Stephanie LaBelle, Senior Analyst at MRG. "Institutions operating within the public health care systems of these European countries are choosing lower-priced devices to meet budgetary constraints."

MRG's new report, European Markets for Interventional Cardiology Devices 2009 (Part II) provides important insight into the reasons behind and extent of the changes
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe
2. New impact factor of European Urology underlines journals outstanding position
3. European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
4. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
5. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
6. Euro RSCG Life Acquires Medicom Group to Further Strengthen Its Global and European Medical Education Offering
7. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
8. Simbionix Signs Agreement With the European Association for Endoscopic Surgery
9. The European Association for the Study of the Liver renews publishing partnership with Elsevier
10. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
11. Prostate screening studies reviewed in European Urology July issue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...PRNewswire-USNewswire/ -- A regional initiative la...iver blindness) in the Americas has substantially ...ars, as evidenced by a 31% decrease in the number ...in six endemic countries. Results were reported t...ciety of Tropical Medicine and Hygiene (ASTMH). ,...
(Date:11/21/2009)... 2009 Test Test Test Tes...t Test Test Test Test Test,Test Test Test Test Tes...t,Test Test Test Test Test Test Test Test Test Tes...st More test More test More test More test,More te...st More test More,test More test , , Please ig...
(Date:11/21/2009)...ve medical apparel company launches men,s lab coat... San Clemente, Calif. (PRWEB) November 21, 200...apparel, today announced the launch of its men,s l...eading international trade fair for the medical in...urates its men,s collection with three varying lab...
(Date:11/21/2009)...Hall, president and chief executive officer of the...e following statement regarding the inclusion of c...nnual wellness for Medicare beneficiaries in "...ot; that was introduced last night: , ...9 -- Eric J. Hall, president and chief executive o...
(Date:11/21/2009)...Group ask whether there is a secret to ,alcohol re... London, UK (PRWEB) November 21, 2009...ree of the adult UK population drinking enough alc...d liver disease*, it is hardly a surprise that man...ammes and residential centres for help. However, f...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
...travenous antiviral drug may be helpful in easing ... which is caused by varicella-zoster virus, is a p...ports that researchers at the University of Colora...ts received 10 milligrams of the drug acyclovir in...
... a high degree of comfort level in ethnically dive...re safer// , and make the students feel wanted. St...ared to other schools. Psychologists from UCLA ...rity of low-income students who belong to the mino...
...f food poisoning, now has a new remedy, which is s... working at the University of Bristol//. The fin...esearchers have narrowed down on a particular anti...ed for the treatment of listeriosis, in spite of i...
...d that there is a need for more talking therapies ... has planned to announce the sites of two talking ...ed at cognitive behavioural therapy (CBT) in help...ts helpline callers show 83% take medication while...
...ties seem to eat healthy food compared to their pe...//. Teenage girls who participate in weight-re...stics and wrestling are more likely to eat breakfa...r team sports. The results of this present study c...
...red by scientists at UCSF, Celera Genomics and The...reased risk// for early heart attack, or myocardia...VAMP8, normally expresses a protein essential for ...ack risk can help identify people at risk and clar...
Other Medicine News:Health News:Comfort Level, Maximum in Ethnically Diverse Schools 2Health News:Comfort Level, Maximum in Ethnically Diverse Schools 3Health News:Gene Variants Linked to Early Heart Attack Discovered 2Health News:Gene Variants Linked to Early Heart Attack Discovered 3Health News:Gene Variants Linked to Early Heart Attack Discovered 4
(Date:11/20/2009)...., Nov. 20 In response ...s why currently available medications designed to ...ECRI Institute, an independent nonprofit organizat...asteride for Prevention of Prostate Cancer for f...ork Times article, " Drugs to Deter Some Cancers ...
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
(Date:11/19/2009)...PRNewswire/ -- In response to an ever-increasing n...medicines, Operation Pangea II, involving 24 count...alth Organization,s International Medical Products...ht the dangers of buying medicines online. ,, T...s of arrests and the seizure of thousands of poten...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2BryanLGH Health System Selects Clinical Xpert From Thomson Reuters to Improve Clinical Quality 55103 1BryanLGH Health System Selects Clinical Xpert From Thomson Reuters to Improve Clinical Quality 55103 2China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 1China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 2China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 3China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 4China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 5China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 6China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 7China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 8China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 9China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 10China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 11China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 12China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 13China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 14China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 15China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 55099 16Austin Texas Cosmetic Dentist Celebrates 30 Years in Practice 55098 1Austin Texas Cosmetic Dentist Celebrates 30 Years in Practice 55098 2Austin Texas Cosmetic Dentist Celebrates 30 Years in Practice 55098 3
...SINESS WIRE)--Apr 16, 2007 - AVAX Technologies,In...presenting the,initial results of its Phase I-II t...anoma at a Clinical Research session of the,meetin... M-Vax(TM),is composed of autologous melanoma cell... the hapten, dinitrophenyl (DNP)., "AVAX is please...
... Extension of Phase I/IIa Trial to 9 mg Dosage,Lev...irstCall/ --,Boston Life Sciences announced today ...y, Cethrin(R), were presented in the Neurotrauma,a...nual Meeting of,the American Association of Neurol...al presentation, "Results of the Cethrin Phase I/I...
Other Medicine Technology:AVAX Technologies Presents Results of Phase I-II M-Vax Trial at,Annual Meeting of American Association for Cancer Research 2AVAX Technologies Presents Results of Phase I-II M-Vax Trial at,Annual Meeting of American Association for Cancer Research 3AVAX Technologies Presents Results of Phase I-II M-Vax Trial at,Annual Meeting of American Association for Cancer Research 4Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 2Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 3Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase,I/IIa 6-Month Results at 75th Annual Meeting of the American,Association of Neurological Surgeons 4
...CellaVision DM96 is an Automated Digital Cell Morp...e-classification/characterization, display, storag...es. Up to 96 stained peripheral blood smears can b... 60 per hour depending on the tests requested. Usi...
Cystoscopy "T". Drape, Sterile
Urological Drape
... the Penilab IV and the Penilab V have an exceptio...tal studies. Model 1060 is similar to the Model 1... can one be added later. The Penilab V has a Dopp... of the accessories you'll need to get started. L...
Medicine Products: